Investor · 1 deal
Every published round Rosrain Investments took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| Ruminant Biotech | Series A | Nov 2025 | $14.8m | Lead | Startup Daily, SmartCompany |
Companies Rosrain Investments has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| Ruminant Biotech | Agritech company tackling methane emissions from cattle | Nov 2025, Series A | 1 | 1 |
Fund closes reported for Rosrain Investments, as distinct from the investments it has made.
Companies Rosrain Investments has backed that another company then bought. An exit for the holding, not a deal Rosrain Investments did.
Stories naming Rosrain Investments. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Funding roundup covering four raises: Pay.com.au's $25 million round plus a $28 million secondary, Ruminant Biotech's Series A, Australis Scientific's Rohto-backed funding, and Paperly's $3 million round led by Tribe Global Ventures.